GlaxoSmithKline Pharmaceuticals Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 7,874.5 million compared to INR 8,096.3 million a year ago. Revenue was INR 8,151.1 million compared to INR 8,283.9 million a year ago. Net income was INR 1,334.3 million compared to INR 12,190.5 million a year ago. Basic earnings per share from continuing operations was INR 7.88 compared to basic loss per share from continuing operations of INR 3.23 a year ago. Basic earnings per share was INR 7.88 compared to INR 71.96 a year ago.
For the full year, sales was INR 32,517.2 million compared to INR 32,780.3 million a year ago. Revenue was INR 33,523.8 million compared to INR 33,538.1 million a year ago. Net income was INR 6,106.9 million compared to INR 16,947.2 million a year ago. Basic earnings per share from continuing operations was INR 35.87 compared to INR 22.48 a year ago. Basic earnings per share was INR 36.05 compared to INR 100.04 a year ago.